INTRODUCTION
============

Hypertension is highly prevalent and corresponds to an important disease burden worldwide \[[@b1-kjim-2019-016]\]. It is important to identify and control the potential risk factors for hypertension to reduce the disease burden. Alcohol is a preventable risk factor for hypertension \[[@b2-kjim-2019-016]-[@b4-kjim-2019-016]\]. Despite its clinical relevance, alcohol-related counselling is not adequately provided in the real world \[[@b5-kjim-2019-016]\]. One of the reasons for insufficient counselling is that there have been inconclusive data regarding the effect of low to moderate doses of alcohol on the development of hypertension \[[@b6-kjim-2019-016]-[@b10-kjim-2019-016]\]. This uncertainty is partly due to diverse clinical settings, including different ethnicities and sex, which results in heterogeneity in body size, body composition, and alcohol metabolism \[[@b6-kjim-2019-016],[@b10-kjim-2019-016]-[@b12-kjim-2019-016]\]. Therefore, the sex-and region (ethnicity)-specific effects should be considered in evaluating the effect of the alcohol dose on the incidence of hypertension.

Most guidelines recommended limiting alcohol consumption to less than 2 units/day for men and less than 1 unit/day for women to control blood pressure \[[@b3-kjim-2019-016],[@b4-kjim-2019-016]\]. However, those guidelines are based on Western data, and it is not clear whether the same strategy can be directly applied to the Asian population. In the current study, we confined our focus to the dose-response relationship in men. In most studies, especially from Asian countries, the amount of alcohol consumed by women is not high enough to draw any significant dose-response relationships \[[@b13-kjim-2019-016],[@b14-kjim-2019-016]\]. More importantly, the disease burden of alcohol-related injury in women is relatively lower than that in men and was less frequently associated with high-risk alcohol consumption features \[[@b15-kjim-2019-016]-[@b18-kjim-2019-016]\]. Although some meta-analyses have evaluated the dose-response relationship between alcohol consumption and hypertension incidence \[[@b19-kjim-2019-016]-[@b21-kjim-2019-016]\], those studies did not primarily evaluate a region-specific effect. More finely tuned convincing data reflecting local and regional characteristics are warranted to establish effective preventive strategies. From this perspective, we performed a systematic review and meta-analysis to clarify the region-varying effect of alcohol dose on hypertension incidence in adult men using contemporary data through December 2017.

METHODS
=======

Search strategy
---------------

We searched the PubMed, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), PsycINFO, Western Pacific Regional Index Medicus, and domestic databases including RISS, KoreaMed, Kmbase, and NDSL for relevant articles published up to December 2017. Manual searching of the references of two previously published systematic reviews and meta-analyses was also performed \[[@b19-kjim-2019-016],[@b20-kjim-2019-016]\]. The detailed search strategy is provided in [Supplementary Table 1](#SD1-kjim-2019-016){ref-type="supplementary-material"}.

Study selection
---------------

Covidence Software, a standard production platform for Cochrane Reviews, was used for screening (<https://www.covidence.org/>). Two independent authors (E.S.S. and S.H.I.) screened the titles and abstracts of the studies identified from the search to eliminate studies that were not relevant to this review. When the title and abstract did not have sufficient information to be screened properly, we retrieved a full-text copy to review. We included studies that met the following criteria: (1) prospective cohort studies and case-control studies on the incidence of hypertension, (2) the exposure was alcohol consumption, (3) at least three categories of alcohol consumption and a unit of alcohol measurement (g/day) were reported, enabling the evaluation of the dose-response relationship, (4) the outcome was the development of hypertension, and hypertension was defined as a blood pressure ≥ 140/90 mmHg and/or taking anti-hypertensive drugs, (5) data were reported separately for men, (6) the study was performed in community or workplace settings, (7) the included subjects were initially free of hypertension, (8) the included subjects were initially free of cancer and severe comorbidities, and (9) the outcome was reported as relative risks, hazard ratios, or odds ratios with 95% confidence intervals (CI). We excluded studies according to the following criteria: (1) review articles, letters, conference abstracts, retrospective cohort studies, master's or doctoral dissertations, and meta-analyses, (2) did not report the incidence of hypertension as the outcome, (3) animal studies, (4) hospitalized populations, (5) inappropriate definition of hypertension (based on self-reported hypertension), and (6) the definition of a non-drinker was ambiguous (did not distinguish social drinkers and/or ex-drinkers). Three investigators (E.S.S., S.H.I., and M.H.J.) rechecked the eligibility of studies for inclusion in the meta-analysis, and any disagreements were resolved by consensus.

Definition of alcohol consumption categories
--------------------------------------------

To determine the dose-response relationships, the alcohol consumption level was stratified into five categories: non-drinkers and low (0.01 to 20.0 g/day), moderate (20.1 to 40.0 g/day), moderate to high (40.1 to 60.0 g/day), and high (\> 60.0 g/day) dose drinkers. Non-drinkers (lifetime abstainers) were allocated to a reference group. To analyse the effects of the different alcohol dosages, the different forms of alcohol consumption were converted to a daily average alcohol consumption (g/day) based on the type of alcohol and the size of a standard drink in the study's country of origin. The midpoint of the consumption ranges was assigned to one of four alcohol categories. When the upper limit of a category was open-ended, we assigned 75% of the previous interval added to the lower limit of that category.

Data extraction and quality assessment
--------------------------------------

Two independent authors (E.S.S. and S.H.I.) extracted data from the selected studies using a data collection form. To minimize problems with the data collection form, we undertook a pilot test and revised the data collection form as needed. We extracted information on the study design, study setting, follow-up duration, age at baseline, number of participants, reference group, comparison by level of alcohol consumption, and controlled variables. Information used in the meta-analysis included odds ratios, relative risks, hazard ratios, 95% CI, total number of participants, and total number of events. Exposure (alcohol)-related information was a measurement unit (g/day), criteria and/or classification of the level of alcohol consumption and data collection method.

We used the Newcastle-Ottawa Scale (NOS) to assess the methodological quality of the included studies \[[@b22-kjim-2019-016]\]. The star system of the NOS consisted of three categories: (1) selection (0 to 4 points), (2) comparability (0 to 2 points), and (3) outcome (0 to 3 points). The scale ranged from 0 to 9, and we considered higher scores of 7 to 9 as high quality ([Supplementary Fig. 1](#SD5-kjim-2019-016){ref-type="supplementary-material"} and [Supplementary Table 2](#SD2-kjim-2019-016){ref-type="supplementary-material"}).

Statistical analysis
--------------------

We expressed the effect size as relative risks with 95% CI. The pooled relative risk estimates were calculated in each alcohol category. To normalize the data, we took the natural logarithms of the relative risk estimates for each level of alcohol consumption from the individual studies and used the natural logarithms of the reported 95% confidence interval to calculate the standard errors of the log relative risk estimates. In cases of missing data, we contacted the corresponding author to acquire the appropriate data for the meta-analysis. We imputed the missing statistics, such as 95% confidence of intervals, after carefully determining the statistics (*p* value) that allowed the calculation. All pooled outcomes were determined using a random-effect model to provide more conservative results than using a fixed-effect model, as suggested by DerSimonian and Laird \[[@b23-kjim-2019-016]\].

The heterogeneity among studies was estimated by the Cochran Q test (*p* \< 0.1 was set to be statistically significant heterogeneity) and the *I*^2^ statistic \[[@b24-kjim-2019-016]\]. We considered studies with an *I*^2^ \> 60% as having substantial heterogeneity. To characterize the region-specific incidence of hypertension according to the level of alcohol consumption, we conducted an analysis stratified by region (Asian vs. Western). We undertook a sensitivity analysis to explore the effects by removing studies with possible sources of heterogeneity one-by-one and recalculating the pooled relative risks for the remaining studies. In cases of heterogeneity (*I*^2^ \> 60%) after the sensitivity analysis, a subsequent subgroup analysis according to age was performed.

Publication bias was visually assessed by the asymmetry of the funnel plot \[[@b25-kjim-2019-016]\] and quantitatively assessed by the Egger test (*p* \< 0.1 was considered statistically significant) \[[@b26-kjim-2019-016]\]. All meta-analyses were conducted using RevMan software version 5.3 (The Nordic Cochrane Center, The Cochrane Collaboration, Copenhagen, Denmark; 2014). R version 3.5 was used to perform the Egger test.

RESULTS
=======

Study characteristics
---------------------

Of 13,578 identified articles, 2,517 duplicated records were excluded. After screening the titles and abstracts, 98 were eligible for review of the full text. After full-text reviews, the final meta-analysis included 11 articles. The detailed reasons for exclusion of some studies that included previous meta-analyses are provided in [Supplementary Table 3](#SD3-kjim-2019-016){ref-type="supplementary-material"} \[[@b27-kjim-2019-016]-[@b31-kjim-2019-016]\]. A flow chart of the study selection is presented in [Fig. 1](#f1-kjim-2019-016){ref-type="fig"}.

The characteristics of the included studies are provided in [Table 1](#t1-kjim-2019-016){ref-type="table"} \[[@b6-kjim-2019-016]-[@b8-kjim-2019-016],[@b13-kjim-2019-016],[@b14-kjim-2019-016],[@b17-kjim-2019-016],[@b32-kjim-2019-016]-[@b36-kjim-2019-016]\]. Seven studies were conducted in Asian countries and four in Western countries. The duration of the follow-up ranged from 3 to 20 years. Among 11 studies, 10 were prospective cohort studies, and one was a case-control study. The included studies had a high quality, as indicated by the nine-star NOS score, and the mean NOS score was 7.5 (ranging from 6 to 9).

Dose-response relationship between the different alcohol consumption categories and the incidence of hypertension: region-specific effect
-----------------------------------------------------------------------------------------------------------------------------------------

We explored the dose-response relationship between alcohol consumption and the incidence of hypertension in each region ([Figs. 2](#f2-kjim-2019-016){ref-type="fig"} and [3](#f3-kjim-2019-016){ref-type="fig"}). Among the Asian populations, a significantly elevated risk was observed even in the low alcohol consumption group, which increased in a dose-dependent manner (pooled relative risks \[95% CI\] were 1.25 \[1.13 to 1.38\], 1.48 \[1.27 to 1.72\], 1.75 \[1.43 to 2.15\], and 1.78 \[1.51 to 2.09\] for the low, moderate, moderate to high, and high alcohol consumption categories, respectively). Among the Western populations, a similar pattern of increased incidence of hypertension (*p* for subgroup difference \> 0.1) according to the amount of alcohol consumption was found; however, a significantly elevated risk was evident only in the high-dose group. Specifically, the pooled relative risks (95% CI) were 1.22 (0.85 to 1.74), 1.57 (0.90 to 2.75), 1.47 (0.44 to 4.91), and 1.49 (1.02 to 2.18) for low, moderate, moderate to high, and high doses of alcohol consumption.

Sensitivity and subgroup analysis
---------------------------------

We further performed a sensitivity analysis by removing each individual study with potential sources of heterogeneity. In general, this process did not affect the dose-response relationships. The results of the sensitivity analysis are provided in [Table 2](#t2-kjim-2019-016){ref-type="table"}. We further performed a subgroup analysis according to age for the Asian population ([Supplementary Table 4](#SD4-kjim-2019-016){ref-type="supplementary-material"}). Generally, a similar graded dose-response relationship was demonstrated regardless of age group (*p* for interaction by age \> 0.1), with a tendency of a steeper slope of the association between alcohol consumption and incidence of hypertension in younger men.

Publication bias
----------------

We did not detect any significant publication bias by visual inspection of the funnel plots ([Supplementary Figs. 2](#SD6-kjim-2019-016){ref-type="supplementary-material"}-[](#SD7-kjim-2019-016){ref-type="supplementary-material"}[](#SD8-kjim-2019-016){ref-type="supplementary-material"}[5](#SD9-kjim-2019-016){ref-type="supplementary-material"}) or by Egger's test (all *p* \> 0.1).

DISCUSSION
==========

The main finding of the current meta-analysis was that there was a graded, dose-dependent increase in risk of hypertension according to alcohol consumption in both Asian and Western men. The risk began at low-dose alcohol consumption (\< 20.0 g/day of alcohol), which is lower than the generally recommended level of consumption (2 units/day = 20--28 g/day) according to most current guidelines. Furthermore, the elevated risk was more evident in the Asian population. Our results provide additional evidence for avoidance of even a low dose of alcohol consumption to prevent the risk of incident hypertension, particularly in Asian men.

Recent guidelines for hypertension have emphasized the importance of lifestyle modification \[[@b3-kjim-2019-016],[@b4-kjim-2019-016]\]. However, controversy still exists regarding low-dose alcohol consumption. Most guidelines permit low-dose alcohol consumption and only limited moderate or greater doses of alcohol consumption \[[@b3-kjim-2019-016],[@b4-kjim-2019-016]\], except for Japanese guidelines \[[@b37-kjim-2019-016]\]. Furthermore, there are heterogeneities in the literature regarding the association between the dose of alcohol consumption and the incidence of hypertension. In this contemporary meta-analysis, we demonstrated that even low-dose alcohol can elevate the risk for the development of future hypertension, and it was especially evident in Asian men. There was no threshold level below which alcohol consumption exerted a beneficial effect on the development of hypertension both in Asian and Western men. Our data, along with a recent meta-analysis \[[@b21-kjim-2019-016]\], could serve as additional evidence in establishing the recommendations in each region.

There have been limited studies regarding the region- or ethnic-specific effects of alcohol dose on the incidence of hypertension. Fuchs et al. \[[@b8-kjim-2019-016]\] previously reported that the pattern of the dose-response relationship differs according to ethnicity in the Atherosclerosis Risk in Communities cohort. Black men had a significantly increased risk of developing hypertension even at low to moderate alcohol consumption, whereas the risk in other groups (white men and women) did not increase with low-dose consumption \[[@b8-kjim-2019-016]\]. A previous meta-analysis showed that Asian men corresponded to a steeper slope for the association with hypertension risk than non-Asian men at a similar alcohol dosage \[[@b19-kjim-2019-016]\]. In the current analysis, although there was no significant group difference between Asian and Western countries, Asian men exhibited a statistically significant risk elevation for each alcohol dose group, whereas Western men corresponded to a marginal graded risk elevation up to moderate to high-dose alcohol consumption (\< 60 g/ day), and a significant risk elevation was only evident for high-dose alcohol consumption (\> 60 g/day). Although the exact mechanism for the region- or ethnic-driven heterogeneity is not clear, different body sizes might play a role. Generally, Asian men are leaner than their Western counterparts. A previous study by Nakanishi et al. \[[@b17-kjim-2019-016]\] showed that, among Japanese men, leaner men are more susceptible to developing hypertension with the same dose of alcohol. A higher blood level of alcohol is expected with a similar dose of alcohol consumption in a leaner individual. In addition, differences in alcohol metabolism based on ethnicity might affect the results. A genetic defect in the alcohol degradation enzyme \[[@b12-kjim-2019-016]\] and differences in the gastric first-pass metabolism of alcohol have been reported in the Japanese population \[[@b38-kjim-2019-016]\]. Other racial differences in the renin-angiotensin-aldosterone system, autonomic nervous system, and nitric oxide bioavailability \[[@b39-kjim-2019-016]-[@b41-kjim-2019-016]\], which are all implicated in alcohol-induced hypertension \[[@b42-kjim-2019-016]\], might contribute to the difference between the Asian and Western populations. Furthermore, environmental and/or cultural factors, such as eating habits, the type of alcohol, and salt intake, might vary between Asian and Western populations. A recent study demonstrated that the risk of metabolic syndrome could also be affected by the timing of alcohol consumption and the type of alcohol consumed \[[@b43-kjim-2019-016]\].

More comprehensive and detailed lifestyle counselling, beyond salt restriction, is needed to prevent the risk of hypertension. Assessing the subject's drinking history (the amount and pattern of alcohol consumption) is the first step, and further, individualized counselling should also be provided. The survey results of the physicians' awareness and implementation of lifestyle modifications were amazingly disappointing. Awareness and the implementation of alcohol moderation were lowest among the various lifestyle modifications. Less than half of physicians (even less than 20% in the worst group) actually advised their patients to moderate their alcohol consumption \[[@b5-kjim-2019-016]\]. Considering the linear dose-response relationship of alcohol on the incidence of hypertension, more attention and proactive counselling, namely restriction of alcohol consumption in Asian men and moderation of alcohol consumption in Western men, is urged.

The present study has several strengths. The definition of a non-drinker pertained exclusively to lifetime abstainers, and we excluded past drinkers and rare drinkers. We reduced the possibility of misclassification originating from self-reported hypertension by limiting the definition of hypertension to a blood pressure of ≥ 140/90 mmHg and/or blood pressure medication use. To identify the effect of low to moderate doses of alcohol on the incidence of hypertension, we meticulously subdivided the alcohol dose categories. To our knowledge, this is the first study to directly evaluate the region-specific influence of alcohol consumption on the incidence of hypertension.

Several limitations also need to be addressed. First, the included studies were all observational studies; thus, we cannot entirely exclude the possibility of unadjusted confounding factors. Second, the amount of alcohol consumed by subjects included in this analysis may be over- or under-estimated due to differences in the types of alcohol, the methods of calculating the amount of alcohol consumption, units of measurement, and recall bias. Third, there might be unadjusted confounding factors, such as socioeconomic, educational, and cultural factors, that were not available in this meta-analysis. Alcohol-induced hypertension is a multi-factorial disease that could be affected by various pathophysiological and environmental factors \[[@b42-kjim-2019-016]\]. Fourth, the tendency to publish only positive results might have affected this meta-analysis. However, we did not find evidence of publication bias in this study.

In summary, in this contemporary meta-analysis that explored the region-specific impact of alcohol on the risk of hypertension, we found that alcohol elevates the risk for future hypertension in a dose-dependent manner, and the risk began at an alcohol consumption level lower than the level recommended in most current guidelines for both Asian and Western men. Furthermore, the elevated risk was more evident in Asian men. Based on this study, it is recommended that Asian men avoid even low-dose alcohol consumption and that Western men avoid high-dose alcohol consumption while limiting their overall alcohol consumption to lower levels. Our findings could serve as additional evidence for developing an appropriate preventive strategy in each region.

KEY MESSAGE
===========

1\. In this contemporary meta-analysis, we found that an increased risk of developing hypertension began in the low-dose alcohol consumption group (\< 20.0 g/day of alcohol), even though that dose was lower than the generally recommended level of alcohol consumption in most current guidelines (2 units/day = 20--28 g/ day). This increased risk was more evident in Asian men than in Western men.

2\. Considering the dose-dependent effect of alcohol consumption on the risk of developing hypertension, it is recommended that Asian men avoid consuming even low doses of alcohol and that Western men avoid consuming high doses of alcohol and limit their overall consumption.
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###### 

Subgroup analysis of the incidence of hypertension by age group among Asian men
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Summary of the quality assessment in non-randomized studies: review the authors' judgement about each assessment item for 10 cohort studies.
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Funnel plot for the studies regarding low dose alcohol at baseline in men. SE, standard error; RR, relative risk.
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Funnel plot for the studies regarding moderate dose alcohol at baseline in men. SE, standard error; RR, relative risk.
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Funnel plot for the studies regarding moderate to high dose alcohol at baseline in men. SE, standard error; RR, relative risk.

###### 

Funnel plot for the studies regarding high dose alcohol at baseline in men. SE, standard error; RR, relative risk.
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![Risk of developing hypertension in each alcohol consumption category, stratified by region. Forest plots for the effect of alcohol dose on hypertension incidence in men: (A) low (0.01 to 20.0 g/day), (B) moderate (20.1 to 40.0 g/day), (C) moderate to high (40.1 to 60.0 g/day), and (D) high (\> 60.0 g/day) doses of alcohol consumption. Each plot is stratified by region (Asian and Western). IV, inverse variance; SE, standard error; CI, confidence interval.](kjim-2019-016f2){#f2-kjim-2019-016}
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###### 

Characteristics of the included studies

  Study                                               Country     Setting     Follow-up, yr            Age range (baseline)   No. of total participants                              No. of total incident cases   Reference group                                               Comparison groups (level of alcohol intake)                                                                     NOS score (1--9)   Study design
  --------------------------------------------------- ----------- ----------- ------------------------ ---------------------- ------------------------------------------------------ ----------------------------- ------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------- ------------------ ---------------
  Diederichs et al. (2017) \[[@b32-kjim-2019-016]\]   German      Community   Mean 11.9 (10.0--14.1)   18--79                 2,231 (men + women)                                    29.0% in Men                  Non-drinkers                                                  \< 20, ≥ 20 g/day (in men)                                                                                      8                  Cohort
  Fuchs et al. (2001) \[[@b8-kjim-2019-016]\]         USA         Community   6                        45--64                 White 3,041                                            White 515                     Non-drinkers                                                  1--209, ≥ 210 g/wk                                                                                              8                  Cohort
  Black 512                                           Black 138                                                                                                                                                                                                                                                                                                                                                     
  Halanych et al. (2010) \[[@b33-kjim-2019-016]\]     USA         Community   20                       18--30                 2,115^[a](#tfn1-kjim-2019-016){ref-type="table-fn"}^   472                           Non-drinkers                                                  Light: \< 7, moderate: 7--14, at risk: \> 14 drinks/wk^[b](#tfn2-kjim-2019-016){ref-type="table-fn"}^           9                  Cohort
  Nakanishi et al. (1998) \[[@b34-kjim-2019-016]\]    Japan       Workplace   6                        30--54                 1,089                                                  340                           Non-drinkers                                                  ≤ 1.9, ≥ 2.0 g/day^[c](#tfn3-kjim-2019-016){ref-type="table-fn"}^                                               7                  Cohort
  Nakanishi et al. (2001) \[[@b17-kjim-2019-016]\]    Japan       Workplace   9                        30--59                 1,130                                                  458                           Non-drinkers                                                  0.1--22.9, 23.0--45.9, 46.0--68.9, ≥ 69.0 g/day                                                                 7                  Cohort
  Nakanishi et al. (2002) \[[@b6-kjim-2019-016]\]     Japan       Workplace   4                        23--35                 1,247                                                  168                           Non-drinkers                                                  \< 12, 12--22, 23--45, ≥ 46 g/day                                                                               7                  Cohort
  36--47                                              1,256       369                                                                                                                                                                                                                                                                                                                                               
  48--59                                              1,281       427                                                                                                                                                                                                                                                                                                                                               
  Ohmori et al. (2002) \[[@b13-kjim-2019-016]\]       Japan       Community   10                       ≥ 40                   433                                                    101                           Non-drinkers^[d](#tfn4-kjim-2019-016){ref-type="table-fn"}^   \< 23, 23--45, 46--68, ≥ 69 g/day                                                                               8                  Cohort
  Okubo et al. (2014) \[[@b14-kjim-2019-016]\]        Japan       Community   Mean 3.4                 40--79                 37,310                                                 16,155                        Non-drinkers                                                  1.0--19.9, 20.0--39.9, 40.0--59.9, ≥ 60.0 g/day                                                                 8                  Cohort
  Park et al. (2006) \[[@b35-kjim-2019-016]\]         Korea       Community   Case 5.2, control 5.3    ≥ 20                   1,329                                                  Case 140, Control 140         Non-drinkers                                                  1--9, 10--20, 20--30, ≥ 30 g/day                                                                                6                  Case- control
  Peng et al. (2013) \[[@b7-kjim-2019-016]\]          China       Workplace   4                        41--65                 32,389                                                 9,151                         Non-drinkers                                                  1--24, 25--49, 50--99, 100--149, ≥ 150 g/day                                                                    7                  Cohort
  Saremi et al. (2004) \[[@b36-kjim-2019-016]\]       USA         Community   Mean 10 (0.9--22)        ≥ 20                   825                                                    192                           Non-drinkers                                                  Light--moderate: occasionally or \< 1 drink/day and 1--2 drink/day, occasional heavy (exclude ≥ 3 drinks/day)   8                  Cohort

NOS, Newcastle-Ottawa Scale.

African-American + European-American.

1 Average drink = 17.2 mL of ethanol.

1 Go = 23 g of ethanol.

Included irregular drinkers who drank less than once a month.

###### 

Hypertension incidence compared to non-drinkers by the level of alcohol consumption

  Alcohol consumption, g/day   Region    No. of studies                                     *I*^2^, % (*p* for heterogeneity)   RR^[a](#tfn5-kjim-2019-016){ref-type="table-fn"}^ (95% CI)         *p* for subgroup difference
  ---------------------------- --------- -------------------------------------------------- ----------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------
  0.01--20.0                   Asian     6                                                  53 (0.06)                           1.25 (1.13--1.38)                                                  0.88 (0.31^[b](#tfn6-kjim-2019-016){ref-type="table-fn"}^)
                               Western   4                                                  68 (0.02)                           1.22 (0.85--1.74)                                                  
                                         3^[c](#tfn7-kjim-2019-016){ref-type="table-fn"}^   58 (0.09)                           1.06 (0.79--1.43)^[c](#tfn7-kjim-2019-016){ref-type="table-fn"}^   
  20.1--40.0                   Asian     7                                                  59 (0.02)                           1.48 (1.27--1.72)                                                  0.84
                               Western   3                                                  44 (0.17)                           1.57 (0.90--2.75)                                                  
  40.1--60.0                   Asian     6                                                  58 (0.04)                           1.75 (1.43--2.15)                                                  0.78
                               Western   1                                                  \-                                  1.47 (0.44--4.91)                                                  
  \> 60.0                      Asian     3                                                  80 (\< 0.01)                        1.78 (1.51--2.09)                                                  0.40 (0.22^[b](#tfn6-kjim-2019-016){ref-type="table-fn"}^)
                                         2^[d](#tfn8-kjim-2019-016){ref-type="table-fn"}^   67 (0.08)                           2.02 (1.49--2.73)^[d](#tfn8-kjim-2019-016){ref-type="table-fn"}^   
                               Western   1                                                  \-                                  1.49 (1.02--2.18)                                                  

RR, relative risk; CI, confidence interval.

Generic inverse variance method, random-effect model.

Sensitivity analysis.

Sensitivity analysis, a repeat of the primary analysis without an effect estimate from Diederichs and Neuhauser \[[@b32-kjim-2019-016]\].

Sensitivity analysis, a repeat of the primary analysis without an effect estimate from Okubo et al. \[[@b14-kjim-2019-016]\].
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